Selbyville, Delaware, Global Antiviral Drugs Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2027. Antiviral Drugs Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Antiviral Drugs market and provides information regarding the revenue for the period 2020 to 2027.

Global Antiviral Drugs Market to reach USD 47.94 billion by 2027. Global Antiviral Drugs Market is valued at approximately USD 37.26 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.2% over the forecast period 2020-2027.

Request a Sample Report of Antiviral Drugs Market at:

Antiviral drugs belong to the class of medication, which used for curing viral infections, such as HIV, hepatitis, influenza, and herpes. Usually, these drugs are overseen in the form of vaccines. In addition, most of these drugs are utilized for viral infections, even though a few broad-spectrum antiviral drugs are efficient alongside a comprehensive range of viruses. These drugs can reduce the ability of flu viruses to produce. When used as directed, antiviral drugs may often help to lessen the duration of flu symptoms in else healthy children and adults and may lower the severity of frequent flu symptoms. Therefore, these factors may promote the adoption of antiviral drugs for the treatment of viral infections all over the world.

Therefore, the rise in prevalence of viral infections, such as HIV and influenza, along with the rise in R&D activities and development of advanced and newer formulations are the few factors responsible for the high CAGR of the market during the forecast period. As per the Avert organization, around 37.9 million people were affected by HIV (including 1.7 million children) in 2018, with a global prevalence of HIV of about 0.8% in the adult population. Similarly, according to the U.S. Department of Health & Human Services, in 2017, roughly 21.7 million individuals living with HIV, representing a surge of 8 million since 2010. Thus, the rise in prevalence of HIV diseases throughout the world will foster the demand for antiviral drugs in the forthcoming period. However, the high cost of drug development, coupled with availability of alternative treatment options, such as homeopathy and naturopathy, are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

Major market player included in this report are:

  • Gilead Sciences
  • Hoffmann-La Roche AG
  • GlaxoSmithKline plc.
  • AbbVie
  • Merck & Co., Inc.
  • Johnson & Johnson Services, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Aurobindo Pharma
  • Reddy’s Laboratories Ltd.

The regional analysis of the global Antiviral Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in availability of sophisticated healthcare infrastructure, and the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of infectious diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Antiviral Drugs market across the Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:



By Application:






By Drug Class:

DNA Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Neuraminidase Inhibitors



  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

For More Details on Antiviral Drugs Market Report at:

About Us:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]

Web site:


Leave a comment

Your email address will not be published. Required fields are marked *